Heart Failure Pharmacology
Sort by:
Houston Methodist DeBakey Heart and Vascular Center
Beyond Atherosclerotic CVD: Prevention of Heart Failure
FEATURING
Kershaw Patel
- 317 views
- October 18, 2021
- 4
Heart Failure 2021
Overview of 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
FEATURING
Theresa Mcdonagh
- 790 views
- October 15, 2021
- 6
Heart Failure 2021
Vericiguat in Heart Failure: Trial Results and Clinical Implications
FEATURING
Burkert Pieske
- 439 views
- October 15, 2021
- 6
Heart Failure 2021
Q&A: Impaired Renal Function in HF Patients, Vericiguat Trial Results
FEATURING
Burkert Pieske
- 99 views
- October 15, 2021
Heart Failure 2021
Potassium Disturbances in Heart Failure: When to Worry and What to Do
FEATURING
Joao Pedro Ferreira
- 422 views
- October 15, 2021
- 1
Heart Failure 2021
Q&A: Management of Hyperkalemia and Heart Failure
FEATURING
Joao Pedro Ferreira
- 168 views
- October 15, 2021
- 2
Houston Methodist DeBakey Heart and Vascular Center
Septal Reduction Therapies for HCM in the Era of Novel Pharmacotherapeutics
FEATURING
Srihari Naidu
- 262 views
- October 12, 2021
- 1
Houston Methodist DeBakey Heart and Vascular Center
Acute Heart Failure and Cardiogenic Shock
FEATURING
Arvind Bhimaraj
- 218 views
- October 1, 2021
- 3
Houston Methodist DeBakey Heart and Vascular Center
Advanced Heart Failure Therapy: LVAD and Heart Transplantation
FEATURING
Rayan Yousefzai
- 124 views
- October 1, 2021
- 1
Houston Methodist DeBakey Heart and Vascular Center
Q&A: Acute Heart Failure and LVADs
- 13 views
- October 1, 2021
Houston Methodist DeBakey Heart and Vascular Center
Chronic Management of Heart Failure: A Guideline Approach
FEATURING
Kavitha Kalvakuri
- 100 views
- September 30, 2021
- 1
Houston Methodist DeBakey Heart and Vascular Center
Diagnosis and Management of Patients With HFpEF and Pulmonary Hypertension
FEATURING
Imad Hussain
- 485 views
- September 30, 2021
- 3
Boston Scientific
Integrated Heart Failure Patient Management — EP and HF Perspective
- 1,162 views
- September 22, 2021
- 8
American Heart & Vascular Institute
Heart Failure With Reduced Ejection Fraction: New Therapies on the Horizon
FEATURING
Nasrien Ibrahim
- 1,163 views
- September 16, 2021
- 9
American Heart & Vascular Institute
Heart Failure With Preserved Ejection Fraction: Is the New Paradigm Treatment Finally Here? Insights from the EMPEROR-Preserved Trial
FEATURING
Javed Butler
- 1,739 views
- September 9, 2021
- 12
American Heart & Vascular Institute
Cardiovascular Updates for Healthcare Professionals: Team Sport of Initiating SGLT2i
FEATURING
Harold Bays
- 439 views
- September 9, 2021
- 4
American Heart & Vascular Institute
Q&A: Understanding SGLT-2 Inhibitors in the CardioNephroEndo Space
- 505 views
- September 9, 2021
CVRx | Barostim
Baroreflex Activation Therapy Overview of Clinical Data
FEATURING
Lana Tsao
- 548 views
- September 6, 2021
- 8
Scripps Health
2021 Primary Care Clinical Trial Highlights: OSA Evals, Breast Cancer Prevention, Hep C Screening, AF and HFrEF
FEATURING
Joel C. Diamant
- 1,261 views
- August 26, 2021
- 5
Scripps Health
2021 Update on HF Pharmacological Management: HF & Cardiac Amyloidosis Therapeutic Approaches and Clinical Trials Overview
FEATURING
Thomas Heywood
- 568 views
- August 25, 2021
- 5
Houston Methodist DeBakey Heart and Vascular Center
Acute Heart Failure: What Is Optimal Medical Therapy?
FEATURING
Christopher O’Connor
- 793 views
- August 24, 2021
- 5
Penn Medicine Heart and Vascular Center
Incorporating SGLT2 Inhibitors into Heart Failure Management
FEATURING
Monique Tanna,
Joyce Wald
- 176 views
- August 17, 2021
Penn Medicine Heart and Vascular Center
Updates on the Diagnosis and Management of Amyloidosis
FEATURING
Brian Drachman
- 320 views
- August 16, 2021
- 4